USD 3.95
(1.8%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | -154.23 Thousand USD | -26.47% |
2022 | -121.95 Thousand USD | -285.17% |
2021 | 65.86 Thousand USD | -58.5% |
2020 | 158.69 Thousand USD | -49.36% |
2019 | 313.36 Thousand USD | 199.05% |
2018 | 104.78 Thousand USD | -58.78% |
2017 | 254.23 Thousand USD | -39.41% |
2016 | 419.58 Thousand USD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q1 | -41.32 Thousand USD | 0.0% |
2024 Q2 | 10.24 Million USD | 24878.22% |
2023 Q1 | -41.93 Thousand USD | -2.5% |
2023 Q2 | -53.01 Thousand USD | -26.43% |
2023 Q4 | -41.32 Thousand USD | 0.0% |
2023 FY | -154.23 Thousand USD | -26.47% |
2023 Q3 | -41.33 Thousand USD | 22.04% |
2022 Q1 | 3261.00 USD | 1864.46% |
2022 Q3 | -58.77 Thousand USD | -130.27% |
2022 Q2 | -25.52 Thousand USD | -882.74% |
2022 FY | -121.95 Thousand USD | -285.17% |
2022 Q4 | -40.91 Thousand USD | 30.39% |
2021 Q4 | 166.00 USD | -99.34% |
2021 FY | 65.86 Thousand USD | -58.5% |
2021 Q3 | 25.3 Thousand USD | 0.0% |
2020 FY | 158.69 Thousand USD | -49.36% |
2019 FY | 313.36 Thousand USD | 199.05% |
2018 FY | 104.78 Thousand USD | -58.78% |
2017 FY | 254.23 Thousand USD | -39.41% |
2016 FY | 419.58 Thousand USD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
American Bio Medica Corporation | -193 Thousand USD | 20.086% |
Arrayit Corporation | 2.57 Million USD | 105.99% |
Biocept, Inc. | -2.58 Million USD | 94.027% |
Bioqual, Inc. | 7.42 Million USD | 102.076% |
CardioGenics Holdings Inc | - USD | Infinity% |
DermTech, Inc. | 276 Thousand USD | 155.882% |
Global WholeHealth Partners Corporation | - USD | Infinity% |
Hangzhou Tigermed Consulting Co., Ltd. | 6.73 Billion USD | 100.002% |
HTG Molecular Diagnostics, Inc. | 1.79 Million USD | 108.597% |
iMD Companies, Inc. | -23.63 Thousand USD | -552.511% |
IDenta Corp. | 662.97 Thousand USD | 123.264% |
Interpace Biosciences, Inc. | 23.04 Million USD | 100.669% |
Integrative Health Technologies, Inc. | 77.57 Thousand USD | 298.829% |
InVitro International | 635.98 Thousand USD | 124.251% |
Lumos Diagnostics Holdings Limited | 6.56 Million USD | 102.35% |
Many Bright Ideas Technologies Inc. | - USD | Infinity% |
Medical Imaging Corp. | 1.09 Million USD | 114.115% |
NovelStem International Corp. | 12 Thousand USD | 1385.283% |
Optigenex Inc. | -102.96 Thousand USD | -49.791% |
PharmChem, Inc. | 3.9 Million USD | 103.95% |
Proteome Sciences plc | 2.09 Million USD | 107.356% |
Response Genetics, Inc | 3.94 Million USD | 103.913% |
Rennova Health, Inc. | 6.26 Million USD | 102.461% |
RushNet, Inc. | 1.1 Million USD | 113.963% |
ScreenPro Security Inc. | 856.57 Thousand USD | 118.006% |
Stella Diagnostics Inc. | - USD | Infinity% |
StageZero Life Sciences Ltd. | -403.74 Thousand USD | 61.799% |
Todos Medical Ltd. | 4.31 Million USD | 103.579% |